NCT07358962 · NOT YET RECRUITING
Mild Cognitive Impairment and Psychopathology
This study is observational, not a drug trial. Researchers are looking at the psychological and emotional profiles of people already diagnosed with mild cognitive impairment, examining how mental health factors like anxiety, depression, and lack of awareness of one's own deficits affect daily functioning. There is no intervention being tested. The phase is unspecified because this is a descriptive research study, not a clinical trial evaluating a treatment.
You may qualify if
- Age between 50 and 72 years;
- Diagnosis of Mild Cognitive Impairment (MCI), with referral to the Neuropsychology clinic for an initial evaluation or for clinical monitoring;
- Absence of behavioral, psychiatric, or sensory disorders that could significantly compromise the performance of cognitive tests or the completion of questionnaires.
You're excluded if
- Neurological disorders other than MCI, such as recent stroke, severe traumatic brain injury, epilepsy, multiple sclerosis, or other atypical neurodegenerative diseases;
- Major psychiatric comorbidities not stabilized at the time of the assessment (e.g., schizophrenia, bipolar disorder in an active phase, untreated severe depression);
- Severe uncorrected sensory deficits (visual or hearing) capable of compromising the validity of cognitive and functional assessments;
- Use of medications with significant potential cognitive impact (e.g., sedatives, high-dose antipsychotics) not stabilized at the time of the assessment;
- Terminal-stage internal or oncological diseases, or other medical conditions that significantly interfere with the assessment procedures.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-01-22